ELISA1: 1,000. Western blot 1: 100 - 1: 500. Immunohistochemistry 1: 10 - 1: 50. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.25 mg/mL
Buffer
PBS with 0.09 % (W/V) sodium azide
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handhabung
Avoid repeated freezing and thawing.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.
BMP6 antikoerper, zgc:113595 antikoerper, vgr antikoerper, vgr-1 antikoerper, vgr1 antikoerper, VGR antikoerper, VGR1 antikoerper, D13Wsu115e antikoerper, Vgr1 antikoerper, bone morphogenetic protein 6 antikoerper, bone morphogenetic protein 6 S homeolog antikoerper, BMP6 antikoerper, bmp6 antikoerper, bmp6.S antikoerper, Bmp6 antikoerper
Hintergrund
The bone morphogenetic proteins (BMPs) are a family of secreted signaling molecules that can induce ectopic bone growth. Many BMPs are part of the transforming growth factor-beta (TGFB) superfamily. BMPs were originally identified by an ability of demineralized bone extract to induce endochondral osteogenesis in vivo in an extraskeletal site. Based on its expression early in embryogenesis, Bmp6 has a proposed role in early development. In addition, the fact that BMP6 is closely related to BMP5 and BMP7 has lead to speculation of possible bone inductive activity.Synonyms: BMP-6, Bone morphogenetic protein 6, VGR, VGR1